Ebook The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth
Obtain the connect to download this The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth and start downloading and install. You can desire the download soft documents of guide The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth by undertaking various other activities. Which's all done. Currently, your count on read a publication is not constantly taking and also carrying the book The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth anywhere you go. You could save the soft documents in your gizmo that will never ever be away and read it as you like. It is like checking out story tale from your device after that. Currently, begin to enjoy reading The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth and also obtain your brand-new life!
The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth
Ebook The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth
Checking out a book The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth is type of very easy activity to do every time you really want. Also reviewing every single time you really want, this activity will certainly not disturb your various other activities; numerous individuals generally read guides The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth when they are having the extra time. Exactly what about you? Exactly what do you do when having the downtime? Do not you spend for pointless points? This is why you need to get guide The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth and aim to have reading practice. Reading this book The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth will certainly not make you useless. It will give a lot more advantages.
Obtaining guides The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth now is not kind of challenging means. You could not only going for book shop or library or borrowing from your pals to read them. This is a very simple way to exactly get guide by online. This on-line e-book The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth could be one of the alternatives to accompany you when having spare time. It will certainly not waste your time. Believe me, the e-book will reveal you brand-new thing to review. Simply spend little time to open this on-line publication The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth and read them anywhere you are now.
Sooner you obtain the e-book The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth, quicker you can appreciate reading the e-book. It will certainly be your rely on maintain downloading the publication The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth in offered link. In this way, you can truly choose that is offered to obtain your own e-book on-line. Right here, be the first to get the e-book qualified The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth as well as be the very first to recognize just how the writer implies the message and also understanding for you.
It will certainly believe when you are going to pick this e-book. This impressive The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth e-book can be checked out completely in particular time depending upon just how frequently you open up as well as read them. One to remember is that every book has their very own production to get by each visitor. So, be the excellent viewers and also be a much better person after reviewing this book The Billion Dollar Molecule: One Company's Quest For The Perfect Drug, By Barry Werth
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing -- atom by atom -- both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.
You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
- Sales Rank: #132902 in Books
- Brand: Werth, Barry
- Published on: 1995-03-01
- Released on: 1995-03-01
- Original language: English
- Number of items: 1
- Dimensions: 8.44" h x 1.20" w x 5.50" l, .90 pounds
- Binding: Paperback
- 464 pages
- Used Book in Good Condition
Amazon.com Review
From test tubes to the Wall Street IPO and beyond, this is the riveting true story of a start-up pharmaceutical company working to create an anti-AIDS drug. Scientifically accurate, yet written with an attention to plot, timing, dialogue, and development of character more characteristic of the best thrillers.
From Publishers Weekly
A startup pharmaceutical company is the focus of this intriguing look at the nexus of biotechnology and high finance; features a new epilogue by the author.
Copyright 1995 Reed Business Information, Inc.
From Library Journal
Werth, a freelance writer on science and business issues, chronicles Joshua Boger's start-up of Vertex, a biotechnology company dedicated to the discovery of new drugs. Boger, a successful organic chemist with Merck, left his position as a senior director to establish Vertex. He recruited an exceptional group of researchers with the aim of integrating the most advanced disciplines in molecular biology to develop an immune-suppressing drug used in organ transplants and a potent HIV protease inhibitor to help thwart AIDS. Werth also discusses Vertex's financing and initial public stock offering. Recommended for science and business collections in public libraries and for special libraries in the pharmaceutical industry.
- Bruce Slutsky, New Jersey Inst. of Tech. Lib., Newark
Copyright 1994 Reed Business Information, Inc.
Most helpful customer reviews
35 of 37 people found the following review helpful.
difficult, fascinating, and compelling birth of a company
By Robert J. Crawford
This is the story of the first few years of Vertex, a bioventure that sought to create drugs that were constructed molecule by molecule - it is supposed to be "rational drug design". In exchange for allowing the company to check his work for accuracy and proprietary disclosures, Werth was admitted into the inner circle of the company, with both executives and scientists, for four years.
Werth offers masterful descriptions of both the science and the intricacies of the busisess deals. The work is similar to that of Tracy Kidder in "The Soul of a New Machine" and, in my opinion, of the same quality.
At the center of the story is Vertex's founding visionary, Joshua Boger, formerly a researcher at Merck. He reasoned that instead of screening soil samples and insect secretions in a hot or miss approach in thousands of petri dishes, he could design drugs atom by atom to bind to - and thus inactivate - molecules instrumental to the disease process. In theory, these drugs would be without side effects: because of the precision of the design, they would adhere to their target alone, allowing beneficial enzymes of other chem reactions to go on unimpeded.
Boger's first target molecule was FKBP, which he believed was a crucial agent of the immune system. By blocking it, he hoped to prevent the host's body from rejecting transplanted organs. While Boger was out raising money (eventually reaching $60 million), Vertex's researchers hunkered down to isolate and analyze FKBP, whose molecular mechanic remained poorly understood.
Unfortunately, what happened is a great example of the difficulties in marrying business to cutting-edge science: after over two years of pushing themselves to the brink of nervous collapse, Vertex scientists found difficulties with FKBP. Even worse, Boger's arch rival, a prof at Harvard, discovered why. The prof beat VErtex, Werth argues, because he remained outside the venture capital game and could thus concentrate totally on the science and could openly collaborate with them rather than hide proprietary results.
Nonetheless, driven and confident as ever, Boger turned his scientific team onto the new problem. Thru all of this, Boger comes off as a fascinating character: the son of a suicide, he is unshakably convinced that he can bend nature as well as the business world to his will. The reader sees what lies behind the herculean efforts of him and his team.
Warmly recommended as a rivetting tale of human endeavor that embraces the true complexity.
14 of 15 people found the following review helpful.
Fast-paced and Insightful
By EarlRandy
I first read this book nearly two years ago as research for a novel I was writing. Recently, I turned to it once more to pick up a few terms and found myself reading chapter after chapter!
This non-fiction tale has enough twists and turns and drama to match any thriller on the market. An informative and engaging tale of a pharmaceutical start-up and the people involved. Joshua is interesting enough that the book could have been solely about him, but he isn't the only one. All of the players in this ego-driven mega-drama are interesting on many levels.
Who would I reccomend this book to? Anyone who likes a well-told story. A background in medicine is not needed, and neither is a knowledge of business practices. All you need to enjoy this book is a brain . . . and a night light because you'll be reading this book deep into the night.
5 of 5 people found the following review helpful.
The Billion Dollar Molecule - One Company's Quest...
By thesheerans
A thouroughly enjoyable read, Werth sheds light on the personaliteis and complexities of an amazing and multifaceted business. Throughout, the author uncovers the unseen deal-making, hand-wringing, and fist clenching that dominate the start of Vertex, a strucure-based paharmaceutical firm.
I particularly enjoyed the background on the Boger-Schreiber collaboration and rivalry, and the ensuing rivalry in Vertex's own labs. Further, following the last few years of Vertex's ups and downs via the Internet has been thoroughly enjoyable.
Werth's style is easliy read, and his obvious unhindered access to Vertex and its people make the story enjoyable, suspenseful, and dramatic.
The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth PDF
The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth EPub
The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth Doc
The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth iBooks
The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth rtf
The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth Mobipocket
The Billion Dollar Molecule: One Company's Quest for the Perfect Drug, by Barry Werth Kindle